QWM
GILD icon

Quadcap Wealth Management’s Gilead Sciences GILD Stock Holding History

Quadcap Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$685K Sell
4,918
-141
-3% -$19.7K 0.08% 215
2025
Q4 		$621K Sell
5,059
-13
-0.3% -$1.58K 0.07% 229
2025
Q3 		$563K Sell
5,072
-30
-0.6% -$3.41K 0.07% 244
2025
Q2 		$566K Buy
5,102
+1,009
+25% +$107K 0.07% 242
2025
Q1 		$459K Buy
+4,093
New +$422K 0.07% 249

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Quadcap Wealth Management's GILD Position: Q1 2026 in Review

Quadcap Wealth Management reduced its Gilead Sciences (GILD) stake by 2.8% in Q1 2026, selling an estimated $19.7K and leaving 4,918 shares worth $685K. The position accounts for 0.08% of the portfolio, ranked #215.

Quadcap Wealth Management first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Quadcap Wealth Management held 4,918 shares of Gilead Sciences worth $685K as of Q1 2026.
  • Quadcap Wealth Management sold 141 Gilead Sciences shares in Q1 2026, an estimated $19.7K.
  • Gilead Sciences made up 0.08% of Quadcap Wealth Management's portfolio in Q1 2026, its #215 holding.
  • Quadcap Wealth Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.